Your browser doesn't support javascript.
loading
Synthesis of 2,8-Dioxabicyclo[3.3.1]nonane Derivatives and Their Neuroprotective Activities.
Kamauchi, Hitoshi; Takanashi, Akifumi; Suzuki, Mitsuaki; Izumi, Kouki; Takao, Koichi; Sugita, Yoshiaki.
Affiliation
  • Kamauchi H; Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.
  • Takanashi A; Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.
  • Suzuki M; Department of Chemistry, Faculty of Science, Josai University.
  • Izumi K; Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.
  • Takao K; Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.
  • Sugita Y; Department of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University.
Chem Pharm Bull (Tokyo) ; 72(1): 56-60, 2024.
Article in En | MEDLINE | ID: mdl-38171905
ABSTRACT
Twenty natural-product-like 2,8-dioxabicyclo[3.3.1]nonane derivatives were synthesized and their neuroprotective activities were tested using human monoamine oxidases (MAO) A and B and acetyl and butyryl cholinesterases (ChE). Compound 1s showed inhibitory activity for MAO-A, MAO-B and acetylcholinesterase (AChE) (IC50 values 34.0, 2.3 and 11.0 µM, respectively). The inhibition mode of (-)-1s for MAO-B was investigated. Chiral HPLC of (±)-1s separated the enantiomers and (-)-1s showed MAO-B inhibitory activity. Molecular docking simulation of (-)-1s and MAO-B revealed the binding mode.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetylcholinesterase / Monoamine Oxidase Inhibitors Limits: Humans Language: En Journal: Chem Pharm Bull (Tokyo) Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Acetylcholinesterase / Monoamine Oxidase Inhibitors Limits: Humans Language: En Journal: Chem Pharm Bull (Tokyo) Year: 2024 Type: Article